The aim of this measure is to strengthen the public's trust in the health care system and to promote understanding for joint cooperation.
The exchange between pharmaceutical companies and members of medical professional groups as well as institutions forms an important basis for developing innovative therapies and ensuring patient care as best as possible. Added value for patient health can only be created if pharmaceutical manufacturers work closely with scientists, doctors and other healthcare professionals.
The knowledge transfer takes place reciprocally:
- For example, Gedeon Richter offers high-quality advanced training so that doctors are well informed about current therapy options and patients are cared for at the highest level and with the latest knowledge. Conversely, doctors in particular have special expertise through their direct contact with patients, which is necessary for the pharmaceutical industry to produce innovative products.
- For this expertise and the time and services doctors provide to pharmaceutical companies, they are remunerated by pharmaceutical manufacturers. The remuneration should be structured appropriately and fairly. Independently of this, the decision of the individual healthcare professional to prescribe, recommend or dispense a certain medicinal product remains unchanged.
The cooperation between Gedeon Richter and doctors and other medical professional groups and institutions is based on clear regulations, in particular Article 9 of the Pharming Code of Conduct. The guiding principle has been and remains high ethical standards, transparency and thus traceability of interactions between the pharmaceutical industry and its partners in the healthcare sector. Gedeon Richter (Switzerland) AG has voluntarily committed itself to transparently documenting cooperation with members of professional groups and institutions.
Monetary benefits from the following areas are published:
- Donations and grants
- Research and development
- Events
- Services and advisory services, including expenses
The disclosure for each member of the professional community and each institution contains individual information ensuring clear identification and the total amount of monetary benefits granted.
Reporting takes place annually, starting with the calendar year, and is published on 30 June of the following year.
In accordance with applicable data protection regulations, Gedeon Richter (Schweiz) AG only publishes personal data with the consent of the professional group members. If consent has not been given, the donations are listed in anonymised, aggregated form.
